MyKidsVision

Eyerising Myopia Management Device

The Eyerising Myopia Management Device uses Repeated Low-Level Red-Light (RLRL) therapy, delivering 650nm visible red light to the back of the eye. This treatment has been shown to improve blood flow and thicken the choroid, which may help address scleral hypoxia linked to myopia progression. The device is supported by more than 40 clinical studies, including two-year trial results showing it can slow myopia progression.

Visit the Eyerising Myopia Management Device website.

Instrument
Eyerising International
Eyerising Myopia Management Device
Myopia control device that delivers repeated low-level red-light (RLRL) to the ocular fundus.
Securely shares patient compliance data with practitioners to monitor efficacy and safe use.
 Light therapies

Articles on Eyerising Myopia Management Device.

What is repeated low-level red light (RLRL) therapy? Parents’ guide
Light therapies

What is repeated low-level red light (RLRL) therapy? Parents’ guide

We explain how repeated low-level red light therapy works to slow myopia progression in children and teenagers, and when they could be a suitable treatment option.

Read full article
Which is the best option for myopia control?
Ortho-kAtropine

Which is the best option for myopia control?

Explore the proven treatments for myopia control – including glasses, soft contact lenses, orthokeratology, atropine eye drops, and light therapies.

Read full article

Join the discussion.

Our social media channels offer a supportive community for those helping their children to manage myopia. It’s a safe, friendly space for parents to access useful resources, ask questions, and share their own experiences with others.